凝血因子Ⅸ(F9)活性蛋白

Active Coagulation Factor IX (F9)

HEMB; FIX; GLA Domain; PTC; Anti Hemophilic Factor B; Christmas Factor; Plasma Thromboplastic Component; Christmas Disease; Hemophilia B

  • 凝血因子Ⅸ(F9)活性蛋白 产品包装(模拟)
  • 凝血因子Ⅸ(F9)活性蛋白 产品包装(模拟)
  • APA840Rb03.jpg Figure. SDS-PAGE
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

活性实验

Coagulation Factor IX, also known as Christmas Factor, is a secreted by the liver and plays a key role in the activation of the intrinsic clotting cascade. Factor IX consists of a Gla domain, two tandem EGF-like domains, an activation peptide, and an S1 serine protease domain. Mature human Factor IX shares approximately 81% amino acid sequence identity with mouse and rat Factor IX. Alternative splicing generates an additional isoform that lacks the first EGF-like domain. The activity of recombinant rabbit Coagulation Factor IX is measured by its ability to cleave a fluorogenic peptide substrate Mca-RPKPVE-Nval-WRK(Dnp)-NH2 in the assay buffer 100 mM Tris, 150 mM NaCl, 10 mM CaCl2, 0.05% (w/v) Brij-35, pH 8.0. The Coagulation Factor IX is diluted to 100 ug/ml in assay buffer, then activated with a final concentration of 10 ug/ml Thermolysin at 37 ℃ for 90min. Adding a final concentration of 10 mM 1,10 Phenanthroline to stop the activation. The activated Coagulation Factor IX is diluted to 6 ug/mL in assay buffer. Loading into a black well plate 50 µL of 6 ug/mL Coagulation Factor IX and start the reaction by adding 50 µL of 20 uM substrate, with a substrate blank containing 50 µL assay buffer, 50 µL substrate, and no Coagulation Factor IX. Then read at 320/405 nm in kinetic mode for 5 minutes. The specific activity of recombinant rabbit Coagulation Factor IX is > 20 pmol/min/µg.

用法

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Oryctolagus cuniculus (Rabbit,兔) 应用(仅供研究使用,不用于临床诊断!)
UAPA840Rb03 凝血因子Ⅸ(F9)活性蛋白 Cell culture; Activity Assays.
URPA840Rb02 凝血因子Ⅸ(F9)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
URPA840Rb03 凝血因子Ⅸ(F9)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
URPA840Rb01 凝血因子Ⅸ(F9)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UPAA840Rb51 凝血因子Ⅸ(F9)多克隆抗体 WB
ULAA840Rb71 凝血因子Ⅸ(F9)多克隆抗体(生物素标记) WB; IHC; ICC.
UMAA840Rb21 凝血因子Ⅸ(F9)单克隆抗体 WB
UMAA840Rb22 凝血因子Ⅸ(F9)单克隆抗体 WB
UFAA840Rb02 抗凝血因子Ⅸ(F9)单克隆抗体 FCM
UFAA840Rb04 抗凝血因子Ⅸ(F9)单克隆抗体 FCM

参考文献

杂志 参考文献
Cardiovascular Research Loss of accelerates arterial thrombosis by increasing formation of neutrophil extracellular traps and plasma tissue factor activity [Pubmed:29444200]
留言咨询